Parallax Volatility Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,900
Closed -$3.33M 1797
2025
Q2
$3.33M Sell
12,900
-6,400
-33% -$1.53M 0.01% 731
2025
Q1
$4.32M Sell
19,300
-8,100
-30% -$1.89M 0.01% 656
2024
Q4
$6.27M Sell
27,400
-27,900
-50% -$6.72M 0.01% 743
2024
Q3
$13.5M Buy
+55,300
New +$12.4M 0.02% 447
2024
Q1
Sell
-9,000
Closed -$1.55M 2265
2023
Q4
$1.55M Buy
9,000
+2,700
+43% +$415K ﹤0.01% 1252
2023
Q3
$932K Buy
6,300
+3,700
+142% +$669K ﹤0.01% 1389
2023
Q2
$568K Buy
+2,600
New +$579K ﹤0.01% 1606
2022
Q4
Sell
-900
Closed -$196K 3197
2022
Q3
$196K Buy
900
+200
+29% +$45.5K ﹤0.01% 2319
2022
Q2
$147K Sell
700
-400
-36% -$85.2K ﹤0.01% 2270
2022
Q1
$267K Sell
1,100
-2,800
-72% -$677K ﹤0.01% 2091
2021
Q4
$1.01M Sell
3,900
-800
-17% -$208K ﹤0.01% 1265
2021
Q3
$1.24M Buy
4,700
+1,100
+31% +$301K ﹤0.01% 1284
2021
Q2
$888K Buy
+3,600
New +$757K ﹤0.01% 1036
2021
Q1
Sell
-3,000
Closed -$639K 2053
2020
Q4
$639K Buy
3,000
+1,700
+131% +$339K ﹤0.01% 1588
2020
Q3
$222K Sell
1,300
-6,300
-83% -$1.16M ﹤0.01% 2516
2020
Q2
$1.46M Buy
7,600
+5,100
+204% +$834K ﹤0.01% 1584
2020
Q1
$368K Buy
+2,500
New +$398K ﹤0.01% 1838
2015
Q1
Sell
-53,800
Closed -$3.02M 5308
2014
Q4
$3.02M Sell
53,800
-57,500
-52% -$3M 0.01% 899
2014
Q3
$5.48M Buy
111,300
+3,800
+4% +$194K 0.02% 684
2014
Q2
$5.44M Buy
+107,500
New +$5.33M 0.02% 456

Other funds holding RMD

Parallax Volatility Advisers's RMD Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of ResMed (RMD) in Q3 2025, closing a stake of 910 shares — an estimated $235K sold.

Parallax Volatility Advisers first reported a position in RMD in Q2 2014 and held it in 19 quarters. The position peaked at $1.01M in Q2 2014. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 910 ResMed shares in Q3 2025, an estimated $235K.
  • Parallax Volatility Advisers first reported a position in ResMed in Q2 2014 and held it in 19 quarters.
  • Parallax Volatility Advisers's ResMed position peaked at $1.01M in Q2 2014.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.